Abexinostat Shows Promise for B Cell Lymphoma
Abexinostat, a novel pan-histone deacetylase inhibitor, is emerging as a promising therapeutic agent for patients with relapsed or refractory B ...
Abexinostat, a novel pan-histone deacetylase inhibitor, is emerging as a promising therapeutic agent for patients with relapsed or refractory B ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine